Jabodon PT Co. cut its position in shares of Anthem Inc (NYSE:ANTM) by 6.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 14,551 shares of the company’s stock after selling 1,034 shares during the quarter. Anthem accounts for approximately 5.2% of Jabodon PT Co.’s holdings, making the stock its 5th largest position. Jabodon PT Co.’s holdings in Anthem were worth $3,988,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. OppenheimerFunds Inc. boosted its position in shares of Anthem by 3.3% in the second quarter. OppenheimerFunds Inc. now owns 2,412,481 shares of the company’s stock worth $574,244,000 after acquiring an additional 77,194 shares during the last quarter. Artisan Partners Limited Partnership boosted its position in shares of Anthem by 40.2% in the second quarter. Artisan Partners Limited Partnership now owns 1,788,388 shares of the company’s stock worth $425,690,000 after acquiring an additional 512,962 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its position in shares of Anthem by 1.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 1,159,985 shares of the company’s stock worth $276,112,000 after acquiring an additional 12,805 shares during the last quarter. Swiss National Bank boosted its position in shares of Anthem by 2.5% in the second quarter. Swiss National Bank now owns 918,241 shares of the company’s stock worth $218,569,000 after acquiring an additional 22,200 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Anthem by 6.4% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 876,010 shares of the company’s stock worth $208,517,000 after acquiring an additional 52,487 shares during the last quarter. Institutional investors and hedge funds own 86.81% of the company’s stock.
Several equities research analysts recently issued reports on ANTM shares. Citigroup cut shares of Anthem from a “buy” rating to a “neutral” rating and set a $162.00 target price on the stock. in a research report on Monday, September 10th. Morgan Stanley raised shares of Anthem from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $273.00 to $368.00 in a research report on Wednesday, September 5th. Jefferies Financial Group reaffirmed a “buy” rating and set a $316.00 price target on shares of Anthem in a research report on Friday, October 12th. Credit Suisse Group lifted their price target on shares of Anthem from $284.00 to $311.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. Finally, Cowen began coverage on shares of Anthem in a research report on Monday, September 17th. They set an “outperform” rating and a $318.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Anthem has a consensus rating of “Buy” and a consensus target price of $292.19.
In related news, EVP Peter D. Haytaian sold 4,500 shares of the company’s stock in a transaction dated Thursday, September 27th. The shares were sold at an average price of $270.00, for a total value of $1,215,000.00. Following the completion of the sale, the executive vice president now owns 51,206 shares of the company’s stock, valued at $13,825,620. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Ronald W. Penczek sold 763 shares of the company’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $265.56, for a total transaction of $202,622.28. Following the completion of the sale, the chief accounting officer now directly owns 1,334 shares of the company’s stock, valued at approximately $354,257.04. The disclosure for this sale can be found here. Insiders sold 15,447 shares of company stock valued at $4,143,846 in the last ninety days. Corporate insiders own 0.31% of the company’s stock.
Anthem stock opened at $272.01 on Wednesday. The stock has a market cap of $69.32 billion, a PE ratio of 22.59, a PEG ratio of 1.38 and a beta of 0.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.53 and a quick ratio of 1.54. Anthem Inc has a one year low of $213.29 and a one year high of $283.06.
Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, October 31st. The company reported $3.81 EPS for the quarter, topping the consensus estimate of $3.70 by $0.11. The business had revenue of $22.98 billion during the quarter, compared to analyst estimates of $22.85 billion. Anthem had a net margin of 4.98% and a return on equity of 13.99%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.65 earnings per share. Equities research analysts predict that Anthem Inc will post 15.65 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Wednesday, December 5th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.10%. The ex-dividend date is Tuesday, December 4th. Anthem’s payout ratio is currently 24.92%.
TRADEMARK VIOLATION WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.dispatchtribunal.com/2018/11/07/jabodon-pt-co-sells-1034-shares-of-anthem-inc-antm.html.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Recommended Story: Asset Allocation
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.